Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Assessment of the Cardiovascular System I: Subjective Data01:23

Assessment of the Cardiovascular System I: Subjective Data

A thorough health history and physical assessment are essential for identifying cardiovascular disease (CVD) symptoms and distinguishing them from other health issues.
Initial Enquiry
Ask the patient about their primary concern and thoroughly explore all reported symptoms.
Medical History
Investigate past illnesses affecting the cardiovascular system, such as angina, anemia, rheumatic fever, congenital heart disease, stroke, thrombophlebitis, dysrhythmias, varicosities
Inquire about symptoms...
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches01:23

Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches

Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast, controlled...
Coronary Artery Disease IV: Preventive Measures01:26

Coronary Artery Disease IV: Preventive Measures

Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
Lifestyle Factors and Health01:20

Lifestyle Factors and Health

Lifestyle factors play a critical role in maintaining overall health and preventing chronic diseases. Key elements, such as regular physical activity, a nutritious diet, and abstinence from smoking, can significantly enhance physical, mental, and emotional well-being while reducing the risk of several life-threatening conditions.
Benefits of Physical Activity
Physical activity, whether through structured exercise or casual activities like walking, biking, or dancing, is a cornerstone of a...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Cross-disciplinary insights on moral injury conceptualization and care: a qualitative study of expert perspectives.

Frontiers in psychiatry·2026
Same author

Perspectives of United States dermatologists on melanoma screening and overdiagnosis: a qualitative study.

Skin health and disease·2026
Same author

Breast, Cervical, and Colorectal Cancer Screening Rates in Women Aged 45 to 64 Years.

JAMA network open·2026
Same author

Increasing Diabetes Self-Management Education and Support Referrals with an Electronic Best Practice Advisory.

Journal of the American Board of Family Medicine : JABFM·2026
Same author

Osteoarthritis physical activity care pathway: Results of an exploratory trial.

Osteoarthritis and cartilage open·2026
Same author

Modeling Tradeoffs in Reminder Intensity and Navigation for Large-Scale Mailed Stool Testing Programs.

American journal of preventive medicine·2025

Related Experiment Videos

Individuals' responses to global CHD risk: a focus group study.

Stacey L Sheridan1, Lindy Behrend, Maihan B Vu

  • 1Division of General Medicine and Clinical Epidemiology, University of North Carolina, Chapel Hill, NC 27599-7110, USA. rolf.wynn@gmail.com

Patient Education and Counseling
|March 17, 2009
PubMed
Summary

Global coronary heart disease (CHD) risk information can motivate individuals to adopt risk-reducing strategies. Patient involvement in decision-making is crucial for effective CHD prevention and management.

Related Experiment Videos

Area of Science:

  • Cardiovascular Health
  • Behavioral Science
  • Health Decision-Making

Background:

  • Coronary heart disease (CHD) poses a significant global health burden.
  • Understanding patient perception of risk is vital for effective prevention strategies.

Purpose of the Study:

  • To investigate how individuals perceive and utilize global CHD risk information.
  • To explore the role of risk information and treatment details in decision-making for risk reduction.

Main Methods:

  • Four focus groups were conducted with 29 individuals at risk for CHD.
  • Verbatim transcripts were analyzed using qualitative coding methods with ATLAS.ti software.

Main Results:

  • Participants found global CHD risk information useful and motivating, despite some concerns about precision.
  • Key decision-making factors included achievable risk, speed of results, and preference for lifestyle changes over medication.
  • Patient participation in decision-making was highlighted as important.

Conclusions:

  • Global CHD risk assessment is a valuable tool for motivating CHD prevention efforts.
  • Tailoring the presentation of risk information and emphasizing patient involvement can enhance CHD outcomes.